Page 334 - Glucose Monitoring Devices
P. 334

Sensor       Dexcom G6  Dexcom G6  Enlite 3  Enlite 3 with  GST3C  transmitter  (continued)






                          Hormone  Insulin  Insulin  Insulin  Insulin  Insulin  Insulin  Insulin  (subcutaneous),  Insulin (inhaled)  Insulin
                   2019.


                   July   device
                   and                 Diabeloop versus  usual care SAP  t:slim X2 with control  IQ versus usual care  640G (FlorenceM,  Cambridge MPC)  Cambridge MPC  Medtronic 670G  DiAS with insulin only  versus DiAS Afrezza low dose versus DiAs  Afrezza high dose

                   May    Infusion                      ForenceM,
                   between  control                          HCL versus standard



                   recruiting  Intervention  versus  “24-hr” versus  “dinner and  overnight”  HCL use  HCL versus SAP  HCL versus usual  care (pump or  injections)  HCL versus CSII  HCL versus MDI  care (CSII or MDI)  Insulin versus low  dose Afrezza versus  high dose Afrezza  HCL versus SAP



                   as  studies
                   listed  Environment  Outpatient, free  living  4 d inpatient,  6 wk outpatient  Outpatient  Outpatient  Outpatient free  living  Outpatient  Inpatient  Outpatient

                   were  Pediatric

                   that  Age  (years)  6e12  6e12  6e13  6e18  10e16  14e18  18e29  phase 1,  18e50  phase 2  18e45
                   ClinicalTrials.gov  (per Duration  arm)  18 wk trial,  18 wk study  extension  6þ wk  4mo þ optional  3 mo extension  6mo  24 mo  6mo  3d  10þ mo








                   on     design
                   listed  Study  Randomized  Open label  Parallel trial  followed by a  nonrandomized  study extension  Randomized  Open label  Crossover  Randomized  Open label  Parallel  Randomized  Open label  Parallel  Randomized  Open label  Parallel  Randomized  Parallel group  Randomized  Open label  Crossover  Randomized  Single-blind  Parallel group

                   studies



                   Closed-loop  Title  Efficacy of closed-  loop insulin therapy  in prepubertal child  in free-life  (FREELIFE-KID)  Diabeloop for kids  (DBL4K)  A study of t:slim X2  with control-IQ  technology (DCLP5)  Day and night  closed-loop in young  people with T1D  (DAN05)  Closed loop from  onset in T1D  Glycemic control  and the brain in  children with T1D  Improving  postprandial blood  glucose control with  Afrezza




                   16.1  trial  NCT03739099  NCT03671915  NCT03844789  NCT02925299  NCT02871089  NCT03428932  studies  NCT03234491  NCT03774186

                   Table  Clinical  ID                             Adult
   329   330   331   332   333   334   335   336   337   338   339